Varicella attenuated live vaccine (GlaxoSmithKline)
水痘减毒活疫苗（葛兰素史克）
Report date: 2022/08/10 15:46:24
Base Information
Drug NameVaricella attenuated live vaccine (GlaxoSmithKline)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2002/06/25
Country/Territory +[9]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesOsaka University
China Registration ClassN/A
Develop Information
Active CompaniesGlaxosmithkline Biological Products Co LtdGlaxosmithkline Plc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksDrugBank